Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinna

Showing results (551-560 of 595) with videos related to

Pageof 60
Sort By:
Bioorganic Chemistry|July 22, 2020
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanesGabriele Murineddu, Battistina Asproni, Paola Corona, et al.
The Biochemical Journal|March 12, 2003
Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activityArianna Donella-Deana, Luca Cesaro, Stefania Sarno, et al.
Transplantation Proceedings|March 27, 2001
Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: a preliminary reportT Kato, S Tamura, A Tekin, et al.
Journal of Medicinal Chemistry|February 7, 2008
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationshipsAdriana Chilin, Roberto Battistutta, Andrea Bortolato, et al.
Journal of Medicinal Chemistry|April 14, 2006
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening applicationGiorgio Cozza, Paolo Bonvini, Elisa Zorzi, et al.
The Biochemical Journal|October 17, 2012
CFTR mutations altering CFTR fragmentationKendra Tosoni, Michelle Stobbart, Diane M Cassidy, et al.
Journal of Medicinal Chemistry|March 17, 2006
Spatial conformation and topography of the tyrosine aromatic ring in substrate recognition by protein tyrosine kinasesPaolo Ruzza, Luca Cesaro, Dirk Tourwé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
Biochemistry|October 6, 2004
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo studyFlavio Meggio, Mario A Pagano, Stefano Moro, et al.
Scientific Reports|February 6, 2019
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regressionZeynep Kabakci, Simon Käppeli, Claudio Cantù, et al.
Pageof 60

Showing results (551-560 of 595) with videos related to

Sort By:
Pageof 60
Bioorganic Chemistry|July 22, 2020
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanesGabriele Murineddu, Battistina Asproni, Paola Corona, et al.
The Biochemical Journal|March 12, 2003
Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activityArianna Donella-Deana, Luca Cesaro, Stefania Sarno, et al.
Transplantation Proceedings|March 27, 2001
Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: a preliminary reportT Kato, S Tamura, A Tekin, et al.
Journal of Medicinal Chemistry|February 7, 2008
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationshipsAdriana Chilin, Roberto Battistutta, Andrea Bortolato, et al.
Journal of Medicinal Chemistry|April 14, 2006
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening applicationGiorgio Cozza, Paolo Bonvini, Elisa Zorzi, et al.
The Biochemical Journal|October 17, 2012
CFTR mutations altering CFTR fragmentationKendra Tosoni, Michelle Stobbart, Diane M Cassidy, et al.
Journal of Medicinal Chemistry|March 17, 2006
Spatial conformation and topography of the tyrosine aromatic ring in substrate recognition by protein tyrosine kinasesPaolo Ruzza, Luca Cesaro, Dirk Tourwé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
Biochemistry|October 6, 2004
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo studyFlavio Meggio, Mario A Pagano, Stefano Moro, et al.
Scientific Reports|February 6, 2019
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regressionZeynep Kabakci, Simon Käppeli, Claudio Cantù, et al.
Pageof 60